The study presented by Dr. Ioanna Kalograiaki at the 29th International Carbohydrate Symposium (ICS 2018) held in Lisbon (Portugal), has been awarded with the JCC prize in the Biomedical Oligosaccharides section.

Tittle: “Advancements in the structural characterisation of an adenocarcinoma-related matrix epitope defined by the monoclonal antibody A10” 

Autors:

Ioanna Kalograiaki,[a] Marcos Viñuela,[b,c] José I. Tudela,[c] Ana I. Manzano,[c] José L. Subiza,[c] and F. Javier Cañada,[a]

[a] Department of Structural & Chemical Biology, Biological Research Center (CIB), Spanish National Research Council (CSIC), Madrid, Spain
[b] Fundación para la Investigación Biomédica, Hospital Clínico San Carlos, Madrid, Spain
[c] Department of Research & Development, Inmunotek S.L., Alcalá de Henares, Spain

This work is part of a research project of INMUNOTEK for the characterization of the Ca10 tumor epitope.  The project has the collaboration of the Molecular Biology Center (CIB-CSIC) and the San Carlos Clinical Hospital of Madrid. The Ca10 tumor epitope is being used for the development of a new carbohydrate-based cancer vaccine.

---